Piper Jaffray Cuts Price Target on Cepheid (CPHD) Following Preliminary 3Q Results
Piper Jaffray maintained an Overweight rating on Cepheid (NASDAQ: CPHD), and cut the price target to $62.00 (from $66.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
